Gregory Tibbitts

Gregory Tibbitts

Director/Board Member chez MAINZ BIOMED N.V.

Fortune : 36 050 $ au 31/03/2024

57 ans
Health Technology
Consumer Services
Finance

Profil

Gregory J.
Tibbitts
is currently the Director at CoImmune, Inc. and Independent Director at Mainz Biomed NV.
He previously worked as Director at IDM Pharma, Inc., Senior Manager-Audit Department at Ernst & Young LLP, Chief Financial Officer at Elitra Pharmaceuticals, Inc., Chief Financial Officer & Vice President-Finance at CryoCor, Inc., Interim Chief Financial Officer at Alsius Corp., Chief Financial Officer at ALUS Liquidation Corp., and Chief Financial Officer at Accumetrics, Inc. He also worked as Controller-Mortgage Banking Division at ITT Financial Corp.
Mr. Tibbitts holds an MBA from San Diego State University and an undergraduate degree from the University of San Diego.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
26/03/2024 35 000 ( 0,21% ) 36 050 $ 31/03/2024

Postes actifs de Gregory Tibbitts

SociétésPosteDébut
MAINZ BIOMED N.V. Director/Board Member 14/12/2022
Director/Board Member 06/07/2021
Tous les postes actifs de Gregory Tibbitts

Anciens postes connus de Gregory Tibbitts

SociétésPosteFin
Director/Board Member 24/06/2009
Director of Finance/CFO 03/05/2009
Director of Finance/CFO 03/05/2009
Director of Finance/CFO 01/05/2008
Director of Finance/CFO 01/06/2004
Voir l'expérience en détail de Gregory Tibbitts

Formation de Gregory Tibbitts

University of San Diego Undergraduate Degree
San Diego State University Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Gregory Tibbitts

Relations

100 +

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
MAINZ BIOMED N.V.

Health Technology

Entreprise privées10

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Gregory Tibbitts